Page last updated: 2024-10-31

1,3-dicyclohexylurea and Hypotension

1,3-dicyclohexylurea has been researched along with Hypotension in 1 studies

1,3-dicyclohexylurea: degradation product of 1-(2-chloroethyl)-3- cyclohexyl-1-nitrosourea; structure

Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.

Research Excerpts

ExcerptRelevanceReference
"05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models."1.34Orally bioavailable potent soluble epoxide hydrolase inhibitors. ( Hammock, BD; Hwang, SH; Liu, JY; Morisseau, C; Tsai, HJ, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, SH1
Tsai, HJ1
Liu, JY1
Morisseau, C1
Hammock, BD1

Other Studies

1 other study available for 1,3-dicyclohexylurea and Hypotension

ArticleYear
Orally bioavailable potent soluble epoxide hydrolase inhibitors.
    Journal of medicinal chemistry, 2007, Aug-09, Volume: 50, Issue:16

    Topics: Adamantane; Administration, Oral; Animals; Benzoates; Biological Availability; Cats; Cricetinae; Dog

2007